TAE Life Sciences
  • Our Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Advisors
    • News
    • Events
    • Careers
  • BNCT
    • History
    • How it Works
    • Benefits of BNCT
    • BNCT Virtual Clinic
  • Pipeline
  • Technology
  • Contact Us
  • TAE.com
  • NEW EBOOK
  • Our Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Advisors
    • News
    • Events
    • Careers
  • BNCT
    • History
    • How it Works
    • Benefits of BNCT
    • BNCT Virtual Clinic
  • Pipeline
  • Technology
  • Contact Us
  • TAE.com
  • NEW EBOOK

Anthony

Home > Anthony
thumbnail_bnctpr2
February 15, 2023

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

Read More
logo_avitabiomedical
January 30, 2023

TLS and Avita Biomedical Announce Strategic Partnership

Read More
southkorea
December 30, 2022

TLS Announces Partnership with HDX for BNCT in South Korea

Read More
logo_businesswire
September 23, 2022

TAE Life Sciences Sponsored Study Details Results of Proton Boron Fusion Therapy Biological Effectiveness

Read More
logo_businesswire
February 12, 2022

TAE Life Sciences to Sponsor Industry Expert Theater “New Era in Biologically-Targeted Radiation Therapy” at 2021 ASTRO Annual Meeting

Read More
logo_businesswire
February 12, 2022

TAE Life Sciences Partners with BEC to Incorporate Specialized Robotic Patient Positioning System in its Alphabeam™ System for High-Precision Boron Neutron Capture Therapy

Read More
logo_businesswire
February 12, 2022

TAE Life Sciences Announces Installation of First Accelerator-based Neutron Beam System for Biologically Targeted Radiation Therapy at Xiamen Humanity Hospital in China

Read More
logo_businesswire
February 12, 2022

TAE Life Sciences Identifies Proprietary Drug Candidates to Support Boron Neutron Capture Therapy (BNCT)

Read More
Developing-targeted-drugs-for-boron-neutron-capture-therapy-to-treat-refractory-cancers
August 21, 2021

Developing targeted drugs for boron neutron capture therapy to treat refractory cancers

Read More
Newer
12
Older

Sign up for our latest news and information

* indicates required




TAE Life Sciences, 35 Parker, Irvine, CA 92618

* The TAE Life Sciences device and drugs are in development and not available for sale or commercial use

Copyright ©2023 TAE Life Sciences. All Rights Reserved. Privacy Policy